John D. Quisel - 29 Dec 2022 Form 4 Insider Report for Disc Medicine, Inc. (IRON)

Reporting owner
Signature
By: /s/ Rahul Khara, as Attorney-in-Fact
Issuer context
Transaction snapshot
SEC evidence
Form type
4
Filing time
03 Jan 2023, 16:05:30 UTC
Next filing
29 Nov 2023
SEC filing
View on sec.gov

Key filing fact

John D. Quisel filed Form 4 for Disc Medicine, Inc. (IRON) on 03 Jan 2023.

Key facts

  • This page summarizes John D. Quisel's Form 4 filing for Disc Medicine, Inc. (IRON).
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 03 Jan 2023, 16:05.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

IRON transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+132,002
Change %
Price
$0.000000
Shares after
132,002
Date
29 Dec 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
132,002
Exercise price
$13.50
Footnotes
F1
* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .